Zobrazeno 1 - 10
of 30
pro vyhledávání: ''
Autor:
Anne Pernille Ofstad, Cathrine Brunborg, Kåre I. Birkeland, Odd Erik Johansen, Lars Gullestad, Martin Heier, Mark S. Borja, Knut Endresen, Michael N. Oda
Publikováno v:
Atherosclerosis. 282:183-187
Background and aims Measures of HDL function are emerging tools for assessing cardiovascular disease (CVD) event risk. HDL-apoA-I exchange (HAE) reflects HDL capacity for reverse cholesterol transport. Methods HAE was measured in 93 participants with
Autor:
Isabella Bonilha, Alexandre A.S. Soares, Wilson Nadruz Junior, Luiz Sergio F. Carvalho, Vitor W.M. Virginio, Orlando Petrucci Junior, Jose C. Quinaglia e Silva, Otavio R. Coelho-Filho, Andrei C. Sposito
Publikováno v:
Atherosclerosis. 281:9-16
Coronary reperfusion with HDL from healthy volunteers attenuates ischemia and reperfusion injury in animal models. In myocardial infarction (MI) patients, such an interaction is unclear. Hence, our first objective was to verify if there is interactio
Autor:
Alberto Cordero, Domingo Orozco-Beltrán, Concepción Carratalá-Munuera, Adriana Lopez-Pineda, Vicente Bertomeu-Martínez, Vicente Bertomeu-González, Vicente Francisco Gil-Guillén, Jose A. Quesada
Publikováno v:
Atherosclerosis
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
r-FISABIO. Repositorio Institucional de Producción Científica
instname
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
r-FISABIO. Repositorio Institucional de Producción Científica
instname
Background and aims: Many studies have reported the independent association between uric acid and cardiovascular disease, its role as a risk predictor for outcomes in people with acute coronary syndrome remains controversial. This study aims to asses
Autor:
Qian Dong, Na-Qiong Wu, Cheng-Gang Zhu, Hui-Hui Liu, Geng Liu, Ying Gao, Yuan-Lin Guo, Di Sun, Ping Qing, Xi Zhao, Jian-Jun Li, Yan Zhang, Sha Li
Publikováno v:
Atherosclerosis. 263:104-111
The atheroprotective role of high-density lipoprotein cholesterol (HDL-C) levels in coronary artery disease (CAD) remains controversial. This study sought to reappraise the value of HDL-C in predicting the severity and outcomes of new-onset patients
Autor:
Michihiko Kitayama, Makoto Watanabe, Taketsugu Tsuchiya, Minako Oda, Kouji Kajinami, Takaaki Takamura, Yasuyuki Kawai, Hironobu Akao, Ryuhei Saito, Ryoko Sato-Ishida
Publikováno v:
Atherosclerosis. 263:192-197
Despite advances in the treatment of peripheral artery disease (PAD), cardiovascular events and death rates remain high. This study aimed at identifying markers of outcome in patients with PAD undergoing endovascular therapy (EVT).Consecutive patient
Publikováno v:
Atherosclerosis. 263:68-73
Background and aimsTumor necrosis factor receptor type 1 (TNFR1) is associated with kidney disease and mortality risk in various populations. Whether or not kidney function mediates mortality risk is unknown. We evaluated associations of TNFR1 levels
Autor:
Kallirhoe Kourea, Nikolaos Liarakos, Elias Tsougos, D Vlastos, George Pavlidis, Helen Triantafyllidi, M. Marinou, John Parissis, John Lekakis, Ioanna Andreadou, Ignatios Ikonomidis
Publikováno v:
Atherosclerosis. 262:123-130
The effects of medically-aided smoking cessation on vascular function and oxidative stress are not fully clarified.One hundred eighty-eight current smokers were randomized to varenicline or nicotine replacement treatment (NRT) for a 3-month period. W
Publikováno v:
Atherosclerosis. 251:454-459
Background and aims Previous results of the AIM-HIGH trial showed that baseline levels of the conventional lipid parameters were not predictive of future cardiovascular (CV) outcomes. The aims of this secondary analysis were to examine the levels of
Autor:
Jiang He, Yanbo Peng, Chongke Zhong, Zhengbao Zhu, Jinchao Wang, Deqin Geng, Qunwei Li, Yongqiu Li, Chung-Shiuan Chen, Yonghong Zhang, Yingxian Sun, Aili Wang, Tan Xu, Hao Peng, Tian Xu
Publikováno v:
Atherosclerosis. 274
Background and aims Serum cystatin C (CysC) is associated with the risk of ischemic stroke and may predict cardiovascular events and death after ischemic stroke onset. However, the association between serum CysC and functional outcome in ischemic str
Autor:
Antoine Guedes, Arnold G. Herman, Bruno Pirenne, Emanuele Barbato, Luc Janssens, Edouard Benit, Patrick Chenu, William Wijns, François Cardinal, Etienne Hoffer, Luc Missault, Jacques Lalmand, Steven Vercauteren
Publikováno v:
Atherosclerosis. 240:351-354
The MEDCOR trial is a double-blind, randomized study aiming at demonstrating the superiority of molsidomine (direct NO donor) over placebo, used as add-on treatments, on improving endothelial function (EF) after 12 months, in stable angina patients u